Winslow Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$586M |
| 2 |
AGN
Allergan plc
AGN
|
+$448M |
| 3 |
Intuit
INTU
|
+$415M |
| 4 |
PayPal
PYPL
|
+$410M |
| 5 |
Edwards Lifesciences
EW
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$520M |
| 2 |
eBay
EBAY
|
+$486M |
| 3 |
Baidu
BIDU
|
+$464M |
| 4 |
Cognizant
CTSH
|
+$370M |
| 5 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$337M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.6% |
| 2 | Consumer Discretionary | 22.45% |
| 3 | Technology | 14.56% |
| 4 | Communication Services | 13.72% |
| 5 | Financials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Zoetis
ZTS
$32.4B
| – | – |
-3,839,032
| Closed | -$185M |
|
|
INOV
77
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $0 | ﹤0.01% |
2
| – | – |
|
|
TFCFA
78
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| – | – |
-8,875,431
| Closed | -$289M |
|
|
MON
79
DELISTED
Monsanto Co
MON
| – | – |
-2,914,231
| Closed | -$311M |
|
|
ARMH
80
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| – | – |
-6,839,938
| Closed | -$337M |
|
Similar funds
Winslow Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Winslow Capital Management held 80 positions worth $27.4B, down 8.8% from $30.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Winslow Capital Management withdrew a net $1.41B in Q3 2015, closing 12 positions and reducing 31 holdings. Its most notable exit was Biogen, an estimated $520M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Winslow Capital Management opened a new position in Bristol-Myers Squibb worth $546M.
- Winslow Capital Management's largest Q3 2015 buy was Bristol-Myers Squibb: 9,229,864 shares worth $546M.
- Winslow Capital Management added most to Amazon in Q3 2015, an estimated $230M increase.
- Winslow Capital Management's biggest Q3 2015 reduction was Cognizant, cutting an estimated $370M.
- Winslow Capital Management fully exited Biogen in Q3 2015, selling an estimated $520M.
- Winslow Capital Management's ten largest holdings make up 35% of its $27.4B portfolio in Q3 2015.
- Winslow Capital Management opened 9 new positions and closed 12 in Q3 2015.
- Winslow Capital Management's portfolio value fell 8.8% quarter-over-quarter to $27.4B.
Based on Winslow Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.